Of chloroquine and COVID-19
F Touret, X de Lamballerie - Antiviral research, 2020 - Elsevier
Recent publications have brought attention to the possible benefit of chloroquine, a broadly
used antimalarial drug, in the treatment of patients infected by the novel emerged …
used antimalarial drug, in the treatment of patients infected by the novel emerged …
Chloroquine and hydroxychloroquine in the treatment of COVID-19 with or without diabetes: A systematic search and a narrative review with a special reference to …
AK Singh, A Singh, A Shaikh, R Singh… - Diabetes & Metabolic …, 2020 - Elsevier
Background and aims No drugs are currently approved for Coronavirus Disease-2019
(COVID-19), although some have been tried. In view of recent studies and discussion on …
(COVID-19), although some have been tried. In view of recent studies and discussion on …
Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases
MAA Al‐Bari - Pharmacology research & perspectives, 2017 - Wiley Online Library
Emerging viruses such as HIV, dengue, influenza A, SARS coronavirus, Ebola, and other
viruses pose a significant threat to human health. Majority of these viruses are responsible …
viruses pose a significant threat to human health. Majority of these viruses are responsible …
Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis
Z Kashour, M Riaz, MA Garbati… - Journal of …, 2021 - academic.oup.com
Objectives Clinical studies of chloroquine (CQ) and hydroxychloroquine (HCQ) in COVID-19
disease reported conflicting results. We sought to systematically evaluate the effect of CQ …
disease reported conflicting results. We sought to systematically evaluate the effect of CQ …
A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease‐19 (COVID‐19)
Objective The pandemic coronavirus disease‐19 (COVID‐19) has pushed the global
healthcare system to a crisis and amounted to a huge economic burden. Different drugs for …
healthcare system to a crisis and amounted to a huge economic burden. Different drugs for …
COVID-19 coronavirus research has overall low methodological quality thus far: case in point for chloroquine/hydroxychloroquine
Abstract Objectives/Background and Objectives Prior epidemics of high-mortality human
coronaviruses, such as the acute respiratory syndrome coronavirus (SARS-CoV or SARS-1) …
coronaviruses, such as the acute respiratory syndrome coronavirus (SARS-CoV or SARS-1) …
[HTML][HTML] Therapeutic use of chloroquine and hydroxychloroquine in COVID-19 and other viral infections: A narrative review
Abstract The rapidly spreading Coronavirus Disease (COVID-19) pandemic, caused by the
severe acute respiratory syndrome coronavirus (SARS-CoV-2), represents an …
severe acute respiratory syndrome coronavirus (SARS-CoV-2), represents an …
Chloroquine and hydroxychloroquine in the treatment of COVID-19: the never-ending story
The anti-malarial drugs chloroquine (CQ) and hydroxychloroquine (HCQ) have been
suggested as promising agents against the new coronavirus SARS-CoV-2 that induces …
suggested as promising agents against the new coronavirus SARS-CoV-2 that induces …
COVID-19 therapeutic options under investigation
M Kaddoura, M AlIbrahim, G Hijazi… - Frontiers in …, 2020 - frontiersin.org
Since its emergence in China in December 2019, COVID-19 has quickly spread around the
globe causing a pandemic. Vaccination or the development of herd immunity seems the only …
globe causing a pandemic. Vaccination or the development of herd immunity seems the only …
A systematic screen of FDA-approved drugs for inhibitors of biological threat agents
Background The rapid development of effective medical countermeasures against potential
biological threat agents is vital. Repurposing existing drugs that may have unanticipated …
biological threat agents is vital. Repurposing existing drugs that may have unanticipated …